Abdennour, Lamine
Sourour, Nader
Drir, Mehdi
Premat, Kévin
Shotar, Eimad
Taylor, Guillaume
Godier, Anne
Mathout, Jugurtha
Lenck, Stéphanie
Bernard, Remy
Carpentier, Alexandre
Degos, Vincent
Clarençon, Frédéric
Article History
Received: 18 March 2019
Accepted: 27 June 2019
First Online: 15 July 2019
Compliance with ethical guidelines
:
: L. Abdennour, M. Drir, K. Premat, E. Shotar, G. Taylor, A. Godier, J. Mathout, S. Lenck, R. Bernard, A. Carpentier and V. Degos declare that they have no competing interests. F. Clarençon reports conflict of interest with Medtronic, Guerbet, Balt Extrusion (payment for readings), Codman Neurovascular (core lab). N. Sourour is consultant for Medtronic, Balt Extrusion, Microvention, Stock/Stock Options: Medina. The other authors report no conflict of interest concerning the materials or methods used in this study or the findings specified in this paper.
: Patient families were informed before each treatment of the strategy that was chosen and gave verbal consent. The need for patient informed consent for retrospective analyses of records and imaging data was waived by the IRB. This work conforms to the World Medical Association Declaration of Helsinki.